Helen Travers

Homozygotes for Huntington's disease

Nancy S. Wexler, Anne B. Young, Rudolph E. Tanzi et al. · Nature · 1987 · 352 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double‐blind, methotrexate‐controlled study of patients with active rheumatoid arthritis

Stanley Cohen, Tien‐Tsai Cheng, Vishala Chindalore et al. · Arthritis & Rheumatism · 2009 · 231 citations

Medicine, Pharmacology, Pharmacotherapy +16

Huntington's disease in Venezuela

Anne B. Young, Ira Shoulson, John B. Penney et al. · Neurology · 1986 · 181 citations · Full text

Medicine, Neurology, Neuroscience +13

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program

Paul Emery, William F. C. Rigby, Paul P. Tak et al. · PLoS ONE · 2014 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial

William F. C. Rigby, H-P Tony, Kurt Oelke et al. · Arthritis & Rheumatism · 2011 · 77 citations

Medicine, Pharmacology, Pharmacotherapy +13